Cytokines in neuroblastoma: from pathogenesis to treatment

Expression of Macrophage Migration Inhibitory Factor by Neuroblastoma Leads to the Inhibition of Antitumor T Cell Reactivity In Vivo

(2014) Q. Zhou et al.   JOURNAL OF IMMUNOLOGY

Plasma midkine level is a prognostic factor for human neuroblastoma

(2010) Shinya Ikematsu et al.   CANCER SCIENCE

Neuroblastoma Progression Correlates with Downregulation of the Lymphangiogenesis Inhibitor sVEGFR-2

(2010) J. Becker et al.   CLINICAL CANCER RESEARCH

Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study

(2010) Suzanne Shusterman et al.   JOURNAL OF CLINICAL ONCOLOGY

Dose Finding Study for the Use of Subcutaneous Recombinant Interleukin-2 to Augment Natural Killer Cell Numbers in an Outpatient Setting for Stage 4 Neuroblastoma After Megatherapy and Autologous Stem-Cell Reinfusion

(2010) Ruth Ladenstein et al.   JOURNAL OF CLINICAL ONCOLOGY

Interferon-β induces apoptosis in human SH-SY5Y neuroblastoma cells through activation of JAK-STAT signaling and down-regulation of PI3K/Akt pathway

(2010) Simona Dedoni et al.   JOURNAL OF NEUROCHEMISTRY

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

(2010) Alice L. Yu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mutation-Independent Anaplastic Lymphoma Kinase Overexpression in Poor Prognosis Neuroblastoma Patients

(2009) L. Passoni et al.   CANCER RESEARCH

Interferon- -Dependent Infiltration of Human T Cells into Neuroblastoma Tumors In vivo

(2009) G. S.D. Reid et al.   CLINICAL CANCER RESEARCH

Increased Intratumoral FOXP3-positive Regulatory Immune Cells during Interleukin-2 Treatment in Metastatic Renal Cell Carcinoma

(2009) H. K. Jensen et al.   CLINICAL CANCER RESEARCH

Prognostic Significance of Interleukin-6 Single Nucleotide Polymorphism Genotypes in Neuroblastoma: rs1800795 (Promoter) and rs8192284 (Receptor)

(2009) J. P. Lagmay et al.   CLINICAL CANCER RESEARCH

HIF-1  and HIF-2  Are Differentially Regulated In vivo in Neuroblastoma: High HIF-1  Correlates Negatively to Advanced Clinical Stage and Tumor Vascularization

(2009) R. Noguera et al.   CLINICAL CANCER RESEARCH

Transient depletion of CD4+ T cells augments IL-21-based immunotherapy of disseminated neuroblastoma in syngeneic mice

(2009) Michela Croce et al.   INTERNATIONAL JOURNAL OF CANCER

Anti-IL-10R antibody improves the therapeutic efficacy of targeted liposomal oligonucleotides

(2009) Chiara Brignole et al.   JOURNAL OF CONTROLLED RELEASE

Immunologic and Therapeutic Synergy of IL-27 and IL-2: Enhancement of T Cell Sensitization, Tumor-Specific CTL Reactivity and Complete Regression of Disseminated Neuroblastoma Metastases in the Liver and Bone Marrow

(2009) R. Salcedo et al.   JOURNAL OF IMMUNOLOGY

CXCR4 expression heterogeneity in neuroblastoma cells due to ligand-independent regulation

(2009) Alex J Carlisle et al.   Molecular Cancer

High incidence of DNA mutations and gene amplifications of theALKgene in advanced sporadic neuroblastoma tumours

(2008) Helena Carén et al.   BIOCHEMICAL JOURNAL

Immunotherapy of neuroblastoma by an Interleukin-21-secreting cell vaccine involves survivin as antigen

(2008) Michela Croce et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Interleukin-6 in the Bone Marrow Microenvironment Promotes the Growth and Survival of Neuroblastoma Cells

(2008) T. Ara et al.   CANCER RESEARCH

Interleukin-6 and Soluble Interleukin-6 Receptor Levels as Markers of Disease Extent and Prognosis in Neuroblastoma

(2008) R. A. Egler et al.   CLINICAL CANCER RESEARCH

Identification of Galectin-3-binding Protein as a Factor Secreted by Tumor Cells That Stimulates Interleukin-6 Expression in the Bone Marrow Stroma

(2008) Yasushi Fukaya et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

IFN-  sensitizes neuroblastoma to the antitumor activity of temozolomide by modulating O6-methylguanine DNA methyltransferase expression

(2008) S. F. Rosati et al.   MOLECULAR CANCER THERAPEUTICS

Identification of ALK as a major familial neuroblastoma predisposition gene

(2008) Yaël P. Mossé et al.   NATURE

Activating mutations in ALK provide a therapeutic target in neuroblastoma

(2008) Rani E. George et al.   NATURE

Oncogenic mutations of ALK kinase in neuroblastoma

(2008) Yuyan Chen et al.   NATURE

Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma

(2008) Isabelle Janoueix-Lerosey et al.   NATURE

Tumor Angiogenesis

(2008) Robert S. Kerbel   NEW ENGLAND JOURNAL OF MEDICINE

The tumor microenvironment and its role in promoting tumor growth

(2008) T L Whiteside   ONCOGENE

Midkine is highly expressed in neuroblastoma tissues

(2008) Henning C. Fiegel et al.   PEDIATRIC SURGERY INTERNATIONAL